By Kenneth E. Thorpe March 28, 2019   Every month, drug companies offer up nearly $13 billion in rebates and other discounts.  Patients don't see these savings at the drugstore, though. The supply chain all but ensures that discounts instead flow to

January 21, 2019   By Kenneth E. Thorpe   The Trump administration is poised to undermine seniors’ access to lifesaving medications.   It recently proposed a rule that would weaken patient protections within Medicare’s “Part D” prescription drug benefit

  PFCD applauds efforts to support the fight against costly chronic disease with rebate reforms   February 1, 2019 (WASHINGTON, D.C) The Partnership to Fight Chronic Disease (PFCD) shared the following statement commending the access improvements in the Administration’s rebate

October 25, 2018 (Washington, D.C.) Addressing the burden of chronic disease to promote better health acutely depends upon enhancing not restricting access to evidence-based preventive and medical care, including physician-administered prescription drugs.  We have grave concerns that the